These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2106031)
1. When is treatment for cancer economically justified? Discussion paper. Jennett B; Buxton M J R Soc Med; 1990 Jan; 83(1):25-8. PubMed ID: 2106031 [No Abstract] [Full Text] [Related]
2. When is treatment for cancer economically justified? Berlin J J R Soc Med; 1990 Dec; 83(12):811-2. PubMed ID: 2088333 [No Abstract] [Full Text] [Related]
3. Who is to live? A question for the economist or the doctor? Williams A World Hosp; 1987 Oct; 23(3-4):34-6. PubMed ID: 10312353 [No Abstract] [Full Text] [Related]
4. QALY league tables. Jefferson T; Mugford M; Demicheli V Health Econ; 1994; 3(3):205. PubMed ID: 7921063 [No Abstract] [Full Text] [Related]
5. Allocating resources. Drummond MF Int J Technol Assess Health Care; 1990; 6(1):77-92. PubMed ID: 2113892 [TBL] [Abstract][Full Text] [Related]
6. Economics, health, and the economics of health. Normand C BMJ; 1991 Dec 21-28; 303(6817):1572-7. PubMed ID: 1773175 [No Abstract] [Full Text] [Related]
7. Fair and effective resource allocation in cancer care: uncharted territory? Green JA; Williams C; Cribb A; Brecher B; Evans M Health Care Anal; 1996 Feb; 4(1):19-44. PubMed ID: 10158435 [No Abstract] [Full Text] [Related]
8. Principles of cost-effective resource allocation in health care organizations. Weinstein MC Int J Technol Assess Health Care; 1990; 6(1):93-103. PubMed ID: 2113893 [TBL] [Abstract][Full Text] [Related]
9. The price of life: ethics and economics. Critique of the report issued by the Minnesota Coalition on Health Care Costs. Bell DC Minn Med; 1985 Feb; 68(2):145-50. PubMed ID: 3974555 [No Abstract] [Full Text] [Related]
10. An imprecise science ... health economics. Dant T Health Serv J; 1988 Aug; 98(5115):968-9. PubMed ID: 10312682 [No Abstract] [Full Text] [Related]
11. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence. Littlejohns P; Barnett D; Longson C; Lancet Oncol; 2003 Apr; 4(4):242-50. PubMed ID: 12681268 [TBL] [Abstract][Full Text] [Related]
12. NICE's citizen's council: what do we ask them, and how? Dolan P; Tsuchiya A; Wailoo A Lancet; 2003 Sep; 362(9387):918-9. PubMed ID: 13678989 [No Abstract] [Full Text] [Related]
13. Placing a value on life and limb: the role of the informed consumer. Eastaugh SR Health Matrix; 1983; 1(1):5-21. PubMed ID: 10310247 [TBL] [Abstract][Full Text] [Related]
14. The price of life: ethics and economics. Minn Med; 1985 Feb; 68(2):139-43. PubMed ID: 3974554 [No Abstract] [Full Text] [Related]
15. Ethics of cancer clinical trials in low-resource settings. Joffe S; Miller FG J Clin Oncol; 2014 Oct; 32(28):3192-6. PubMed ID: 25185082 [No Abstract] [Full Text] [Related]
16. Why not real economics? Johnson FR Pharmacoeconomics; 2012 Feb; 30(2):127-31. PubMed ID: 22185186 [No Abstract] [Full Text] [Related]
17. The economic evaluation of cancer treatments and programmes. Goddard M; Drummond M Eur J Cancer; 1991; 27(10):1191-6. PubMed ID: 1835583 [No Abstract] [Full Text] [Related]
18. Cost-effectiveness in oncology. Rees GJ Lancet; 1985 Dec 21-28; 2(8469-8470):1405-8. PubMed ID: 11658649 [TBL] [Abstract][Full Text] [Related]
19. Health economics of care for patients with cancer and intractable disease in Japan. Hisashige A; Katayama T; Mikasa H Support Care Cancer; 1998 Nov; 6(6):503-10. PubMed ID: 9833298 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness league tables: more harm than good? Drummond M; Torrance G; Mason J Soc Sci Med; 1993 Jul; 37(1):33-40. PubMed ID: 8332922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]